DO Dow Jones Newswires Vertex Pharmaceuticals to Buy Crinetics Pharmaceuticals for $85 a Share in Cash >VRTX CRNX 7/7/2026, 04:05 am GMT+8 Dow Jones Newswires CR CRNX VR VRTX Sources Dow Jones Newswires Active symbols NASDAQ:CRNX, NASDAQ:VRTX Language English (India) Vertex Pharmaceuticals to Buy Crinetics Pharmaceuticals for $85 a Share in Cash >VRTX CRNX Market News PR Newswire The Longevity Protein Race Reaches Manufacturing: One Microcap Just Completed A GMP Master Cell Bank For Its Anti-Aging Klotho Therapy Stocktwits VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal? GuruFocus Vertex Pays $10 Billion to Enter Rare Endocrine Disease Dow Jones Newswires Vertex Doesn't Need Crinetics Deal to Generate $5 Billion to Be Success, Evercore Says — Market Talk
